Li Shi

477 total citations
26 papers, 307 citations indexed

About

Li Shi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Li Shi has authored 26 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Li Shi's work include Lung Cancer Treatments and Mutations (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and RNA modifications and cancer (3 papers). Li Shi is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and RNA modifications and cancer (3 papers). Li Shi collaborates with scholars based in China, United States and United Kingdom. Li Shi's co-authors include Jing Zhao, Yi Gao, P. S. Levy, H. Daniel Roth, Zesong Li, Chunlan Wang, Yang Liu, Hongbing Mei, Han Wang and Hua Wang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Oncogene.

In The Last Decade

Li Shi

26 papers receiving 301 citations

Peers

Li Shi
Masaru Fukahori Japan
Yiqing Li China
Zhaoyang Lu China
Zhanxiong Xue China
Hongbin Gao China
Maja Henjakovic Germany
Wenhui Chen China
Yasuhiko Mitsuke Japan
Ningning Mi China
Masaru Fukahori Japan
Li Shi
Citations per year, relative to Li Shi Li Shi (= 1×) peers Masaru Fukahori

Countries citing papers authored by Li Shi

Since Specialization
Citations

This map shows the geographic impact of Li Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Shi more than expected).

Fields of papers citing papers by Li Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Shi. The network helps show where Li Shi may publish in the future.

Co-authorship network of co-authors of Li Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Li Shi. A scholar is included among the top collaborators of Li Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Shi. Li Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shi, Liqin, et al.. (2024). The p38 MAPK/snail signaling axis participates in cadmium-induced lung cancer cell migration and invasiveness. Environmental Science and Pollution Research. 31(16). 24042–24050. 2 indexed citations
3.
Shi, Li, et al.. (2024). Topical riboflavin versus 5-aminolevulinic acid photodynamic therapy for the treatment of mild to moderate acne: A split-face randomized study. Photodiagnosis and Photodynamic Therapy. 51. 104449–104449. 1 indexed citations
4.
Du, Danyu, Mengyao Qin, Li Shi, et al.. (2023). RNA binding motif protein 45-mediated phosphorylation enhances protein stability of ASCT2 to promote hepatocellular carcinoma progression. Oncogene. 42(42). 3127–3141. 10 indexed citations
5.
Gao, Yi, et al.. (2022). Combination therapy with rifaximin and lactulose in hepatic encephalopathy: A systematic review and meta-analysis. PLoS ONE. 17(4). e0267647–e0267647. 18 indexed citations
6.
Li, Chuanyin, et al.. (2021). The associations and roles of microRNA single-nucleotide polymorphisms in cervical cancer. International Journal of Medical Sciences. 18(11). 2347–2354. 4 indexed citations
7.
Shi, Li, et al.. (2020). Human cytomegalovirus protein UL136 activates the IL-6/STAT3 signal through MiR-138 and MiR-34c in gastric cancer cells. International Journal of Clinical Oncology. 25(11). 1936–1944. 11 indexed citations
8.
Ma, Juan, Lingling Xia, Xueqing Yao, et al.. (2020). BARX2 expression is downregulated by CpG island hypermethylation and is associated with suppressed cell proliferation and invasion of gastric cancer cells. Oncology Reports. 43(6). 1805–1818. 10 indexed citations
9.
Gu, Wen, et al.. (2020). Integrated fate assessment of aromatic amines in aerobic sewage treatment plants. Environmental Monitoring and Assessment. 192(5). 16 indexed citations
10.
Ko, Andrew H., Jeeyun Lee, María Alsina, et al.. (2020). Phase Ib/II open-label, randomized evaluation of 2L atezolizumab (atezo) + PEGPH20 versus control in MORPHEUS-pancreatic ductal adenocarcinoma (M-PDAC) and MORPHEUS-gastric cancer (M-GC).. Journal of Clinical Oncology. 38(15_suppl). 4540–4540. 7 indexed citations
11.
12.
Wang, Yun, Xudong Zhang, Jianhua Fu, et al.. (2019). Potential applications of nanoparticles for tumor microenvironment remodeling to ameliorate cancer immunotherapy. International Journal of Pharmaceutics. 570. 118636–118636. 27 indexed citations
13.
Liu, Yang, Han Wang, Beibei Ni, et al.. (2019). <p>Loss of <em>KCNJ15</em> expression promotes malignant phenotypes and correlates with poor prognosis in renal carcinoma</p>. Cancer Management and Research. Volume 11. 1211–1220. 24 indexed citations
14.
Wang, Hua, et al.. (2019). Relationships among resistin, adiponectin, and leptin and microvascular complications in patients with type 2 diabetes mellitus. Journal of International Medical Research. 48(4). 1219669959–1219669959. 16 indexed citations
15.
Ni, Beibei, Li Shi, Yang Liu, Yuqian Huang, & Zesong Li. (2018). Prognostic value of spleen tyrosine kinase in human solid tumors. OncoTargets and Therapy. Volume 11. 3377–3384. 2 indexed citations
16.
Xu, Jianfeng, Zhiguang Zhao, Lele Ye, et al.. (2017). Prognostic significance of Daxx NCR (Nuclear/Cytoplasmic Ratio) in gastric cancer. Cancer Medicine. 6(9). 2063–2075. 19 indexed citations
17.
Rebelatto, Marlon C., Amita Mistry, Jill Walker, et al.. (2015). Development of a PD-L1 companion diagnostic assay for treatment with MEDI4736 in NSCLC and SCCHN patients.. Journal of Clinical Oncology. 33(15_suppl). 8033–8033. 25 indexed citations
18.
Chen, Yongbing, et al.. (2011). XAF1 as a prognostic biomarker and therapeutic target in squamous cell lung cancer.. PubMed. 124(20). 3238–43. 11 indexed citations
19.
Shi, Li. (2009). Occurrence of Depressive and/or Anxiety Disorders in Neurological Outpatients from General Hospitals in Beijing. Zhongguo xinli weisheng zazhi. 1 indexed citations
20.
Roth, H. Daniel, et al.. (1994). Alcoholic beverages and breast cancer: Some observations on published case-control studies. Journal of Clinical Epidemiology. 47(2). 207–216. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masaru Fukahori Breakdown of academic impact, for papers by Yiqing Li Breakdown of academic impact, for papers by Zhaoyang Lu Breakdown of academic impact, for papers by Zhanxiong Xue Breakdown of academic impact, for papers by Hongbin Gao Breakdown of academic impact, for papers by Maja Henjakovic Breakdown of academic impact, for papers by Wenhui Chen Breakdown of academic impact, for papers by Yasuhiko Mitsuke Breakdown of academic impact, for papers by Ningning Mi
Rankless by CCL
2026